Trial Profile
An open-label, randomized, single-dose, four-treatment crossover study to evaluate platelet function in healthy adult male volunteers following administration of intravenous diclofenac sodium (DIC075V 37.5 mg) [Dyloject], oral diclofenac potasssium (Cataflam 50 mg), intravenous ketorolac tromethamine 30 mg and acetylsalicylic acid (ASA 325 mg) [aspirin]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2011
Price :
$35
*
At a glance
- Drugs Diclofenac potassium (Primary) ; Aspirin; Diclofenac; Ketorolac
- Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Javelin Pharmaceuticals
- 09 Jan 2008 Status change from recruiting to completed.
- 03 Nov 2007 New trial record.